Skip to main content
SpringerLink
Log in

Procollagen C-proteinase enhancer-1 and renal failure in multiple myeloma

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Background

Renal involvement is present in approximately 50% of multiple myeloma (MM) cases and is associated with a poor prognosis. Procollagen C-Proteinase Enhancer 1 (PCPE-1) is an extracellular matrix glycoprotein that has been shown to increase collagen production by enhancing the activity of Procollagen C-Proteinase (PCP) involved in collagen fibrillogenesis and contribute to the fibrotic process. This study investigates the relationship between PCPE-1 and renal function in myeloma patients.

Methods

Eighty-one adults, consisting of 61 patients diagnosed with MM and 20 healthy controls, were included in this cross-sectional study. The MM patients with renal injury (RI) were classified as “MM-RI( +)” and those with no RI as “MM-RI(−)”.

Results

The median serum PCPE-1 level was 10.7 (5.0–39.4) ng/mL for the entire study population, 9.9 (5.0–13.6) ng/mL for the control group, 10.0 (6.4–22.5) ng/mL for the MM-RI(−) group, and 11.4 (8.1–39.4) ng/mL for the MM-RI( +) group. The difference between the control group and MM-RI( +) group was statistically significant (p < 0.013). PCPE-1 levels negatively correlated with estimated glomerular filtration rate (eGFR), serum albumin, and hemoglobin levels but positively correlated with serum creatinine and CRP levels in the entire study population. Among MM patients, only serum phosphorus and beta-2-microglobulin (β2M) were positively correlated with PCPE-1. PCPE-1 levels was not affected by other parameters in the entire study population and in the MM group.

Conclusions

Although serum PCPE-1 was higher in the MM-RI( +) group, it was thought to be associated with low GFR reflecting non-specific kidney injury rather than myeloma-related kidney injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sakhuja V, Jha V, Varma S, Joshi K, Gupta KL, Sud K et al (2000) Renal involvement in multiple myeloma: a 10-year study. Ren Fail 22(4):465–477

    Article  CAS  Google Scholar 

  2. Dimopoulos MA, Terpos E, Chanan-Khan A, Leung N, Ludwig H, Jagannath S et al (2010) Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group. J Clin Oncol 28(33):4976–4984

    Article  Google Scholar 

  3. Gonsalves WI, Leung N, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR et al (2015) Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma. Blood Cancer J 5:e296

    Article  CAS  Google Scholar 

  4. Palumbo A, Avet-Loiseau H, Oliva S, Lokhorst HM, Goldschmidt H, Rosinol L et al (2015) Revised international staging system for multiple myeloma: a report from international myeloma working group. J Clin Oncol 33(26):2863–2869

    Article  CAS  Google Scholar 

  5. Doshi M, Lahoti A, Danesh FR, Batuman V, Sanders PW, American Society of Nephrology Onco-Nephrology F (2016) Paraprotein-related kidney disease: kidney injury from paraproteins-what determines the site of injury? Clin J Am Soc Nephrol. 11(12):2288–94

    Article  CAS  Google Scholar 

  6. Heher EC, Rennke HG, Laubach JP, Richardson PG (2013) Kidney disease and multiple myeloma. Clin J Am Soc Nephrol 8(11):2007–2017

    Article  CAS  Google Scholar 

  7. Walk JC, Ayati BP, Holstein SA (2019) Modeling the effects of multiple myeloma on kidney function. Sci Rep 9(1):1726

    Article  Google Scholar 

  8. Lockhart-Cairns MP, Baldock C (2018) Unraveling the mechanism of procollagen C-proteinase enhancer. Structure 26(10):1299–1301

    Article  CAS  Google Scholar 

  9. Tovar-Vidales T, Fitzgerald AM, Clark AF, Wordinger RJ (2013) Transforming growth factor-beta2 induces expression of biologically active bone morphogenetic protein-1 in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 54(7):4741–4748

    Article  CAS  Google Scholar 

  10. Kessler E, Takahara K, Biniaminov L, Brusel M, Greenspan DS (1996) Bone morphogenetic protein-1: the type I procollagen C-proteinase. Science 271(5247):360–362

    Article  CAS  Google Scholar 

  11. Ozkan G, Guzel S, Atar RV, Fidan C, Kara SP, Ulusoy S (2019) Elevated serum levels of procollagen C-proteinase enhancer-1 in patients with chronic kidney disease is associated with a declining glomerular filtration rate. Nephrology (Carlton) 24(9):938–942

    Google Scholar 

  12. Mesilaty-Gross S, Anikster Y, Vilensky B, Wolf I, Phillip M, Gat-Yablonski G (2009) Different patterns of human serum procollagen C-proteinase enhancer1 (PCPE1). Clin Chim Acta 403(1–2):76–80

    Article  CAS  Google Scholar 

  13. Shalitin N, Schlesinger H, Levy MJ, Kessler E, Kessler-Icekson G (2003) Expression of procollagen C-proteinase enhancer in cultured rat heart fibroblasts: evidence for co-regulation with type I collagen. J Cell Biochem 90(2):397–407

    Article  CAS  Google Scholar 

  14. Woziwodzka K, Vesole DH, Malyszko J, Batko K, Jurczyszyn A, Koc-Zorawska E et al (2020) New markers of renal failure in multiple myeloma and monoclonal gammopathies. J Clin Med 9(6):1652

    Article  CAS  Google Scholar 

  15. Argyropoulos CP, Chen SS, Ng YH, Roumelioti ME, Shaffi K, Singh PP et al (2017) Rediscovering beta-2 microglobulin as a biomarker across the spectrum of kidney diseases. Front Med (Lausanne) 4:73

    Article  Google Scholar 

  16. Relini A, Canale C, De Stefano S, Rolandi R, Giorgetti S, Stoppini M et al (2006) Collagen plays an active role in the aggregation of beta2-microglobulin under physiopathological conditions of dialysis-related amyloidosis. J Biol Chem 281(24):16521–16529

    Article  CAS  Google Scholar 

  17. Morimoto H, Wada J, Font B, Mott JD, Hulmes DJ, Ookoshi T et al (2008) Procollagen C-proteinase enhancer-1 (PCPE-1) interacts with beta2-microglobulin (beta2-m) and may help initiate beta2-m amyloid fibril formation in connective tissues. Matrix Biol 27(3):211–219

    Article  CAS  Google Scholar 

  18. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612

    Article  Google Scholar 

  19. Stevens PE, Levin A (2013) Kidney disease: improving global outcomes chronic kidney disease guideline development work group M. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 158(11):825–30

    Article  Google Scholar 

  20. Augustson BM, Begum G, Dunn JA, Barth NJ, Davies F, Morgan G et al (2005) Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom medical research council trials between 1980 and 2002–medical research council adult Leukaemia working party. J Clin Oncol 23(36):9219–9226

    Article  Google Scholar 

  21. Ying WZ, Li X, Rangarajan S, Feng W, Curtis LM, Sanders PW (2019) Immunoglobulin light chains generate proinflammatory and profibrotic kidney injury. J Clin Invest 129(7):2792–2806

    Article  Google Scholar 

  22. Li M, Hering-Smith KS, Simon EE, Batuman V (2008) Myeloma light chains induce epithelial-mesenchymal transition in human renal proximal tubule epithelial cells. Nephrol Dial Transplant 23(3):860–870

    Article  Google Scholar 

  23. Ogata I, Auster AS, Matsui A, Greenwel P, Geerts A, D’Amico T et al (1997) Up-regulation of type I procollagen C-proteinase enhancer protein messenger RNA in rats with CCl4-induced liver fibrosis. Hepatology 26(3):611–617

    Article  CAS  Google Scholar 

  24. Adar R, Kessler E, Goldberg B (1986) Evidence for a protein that enhances the activity of type I procollagen C-proteinase. Coll Relat Res 6(3):267–277

    Article  CAS  Google Scholar 

  25. Hulmes DJ, Mould AP, Kessler E (1997) The CUB domains of procollagen C-proteinase enhancer control collagen assembly solely by their effect on procollagen C-proteinase/bone morphogenetic protein-1. Matrix Biol 16(1):41–45

    Article  CAS  Google Scholar 

  26. Lagoutte P, Bettler E, Vadon-Le Goff S, Moali C (2021) Procollagen C-proteinase enhancer-1 (PCPE-1), a potential biomarker and therapeutic target for fibrosis. Matrix Biol Plus 11:100062

    Article  CAS  Google Scholar 

  27. Tummalapalli L, Nadkarni GN, Coca SG (2016) Biomarkers for predicting outcomes in chronic kidney disease. Curr Opin Nephrol Hypertens 25(6):480–486

    Article  CAS  Google Scholar 

  28. Benseny-Cases N, Karamanos TK, Hoop CL, Baum J, Radford SE (2019) Extracellular matrix components modulate different stages in beta2-microglobulin amyloid formation. J Biol Chem 294(24):9392–9401

    Article  CAS  Google Scholar 

  29. Giorgetti S, Rossi A, Mangione P, Raimondi S, Marini S, Stoppini M et al (2005) Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. Protein Sci 14(3):696–702

    Article  CAS  Google Scholar 

  30. Ledo N, Ko YA, Park AS, Kang HM, Han SY, Choi P et al (2015) Functional genomic annotation of genetic risk loci highlights inflammation and epithelial biology networks in CKD. J Am Soc Nephrol 26(3):692–714

    Article  CAS  Google Scholar 

Download references

Funding

The research did not receive funding from any sources.

Author information

Authors and Affiliations

  1. Department of Nephrology, School of Medicine, Tekirdag Namik Kemal University, 59030, Tekirdağ, Turkey

    Nergiz Bayrakci & Gülsüm Özkan

  2. Department of Hematology, School of Medicine, Tekirdag Namik Kemal University, Tekirdağ, Turkey

    Seval Akpinar

  3. Department of Internal Medicine, School of Medicine, Tekirdag Namik Kemal University, Tekirdağ, Turkey

    Bartu Ediz

  4. Department of Biochemistry, School of Medicine, Tekirdag Namik Kemal University, Tekirdağ, Turkey

    Ahsen Yilmaz & Aliye Çelikkol

Authors
  1. Nergiz Bayrakci
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gülsüm Özkan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Seval Akpinar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bartu Ediz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ahsen Yilmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Aliye Çelikkol
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nergiz Bayrakci.

Ethics declarations

Conflict of interest

The authors have no conflict of interest to report.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bayrakci, N., Özkan, G., Akpinar, S. et al. Procollagen C-proteinase enhancer-1 and renal failure in multiple myeloma. Int Urol Nephrol 54, 3033–3038 (2022). https://doi.org/10.1007/s11255-022-03378-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-022-03378-z

Keywords

Search

Navigation